Metastasis: the seed and soil theory gains identity
暂无分享,去创建一个
Frank Rose | Rita Engenhart-Cabillic | E. Fokas | K. Daniilidis | F. Rose | R. Engenhart-Cabillic | Emmanouil Fokas | H. An | Kiriakos Daniilidis | Han-Xiang An
[1] Kerstin Lang,et al. Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters. , 2004, The Lancet. Oncology.
[2] Xin Wei Wang,et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. , 2006, Cancer cell.
[3] S. Mohan,et al. Osteogenic Protein-1 Stimulates mRNA Levels of BMP-6 and Decreases mRNA Levels of BMP-2 and -4 in Human Osteosarcoma Cells , 1997, Calcified Tissue International.
[4] D. Mukhopadhyay,et al. Effect of Rapamycin Alone and in Combination with Antiangiogenesis Therapy in an Orthotopic Model of Human Pancreatic Cancer , 2004, Clinical Cancer Research.
[5] J. Chirgwin,et al. Basic Mechanisms Responsible for Osteolytic and Osteoblastic Bone Metastases , 2006, Clinical Cancer Research.
[6] Z. Werb,et al. New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.
[7] Q. Zeng,et al. Generation of PRL-3- and PRL-1-Specific Monoclonal Antibodies as Potential Diagnostic Markers for Cancer Metastases , 2005, Clinical Cancer Research.
[8] L. Qin,et al. Overexpression of Platelet-Derived Growth Factor Receptor α in Endothelial Cells of Hepatocellular Carcinoma Associated with High Metastatic Potential , 2005, Clinical Cancer Research.
[9] G. Mundy. Endothelin-1 and osteoblastic metastasis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[10] E. Ruoslahti,et al. Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. , 2004, Cancer cell.
[11] Li Mao,et al. Global expression-based classification of lymph node metastasis and extracapsular spread of oral tongue squamous cell carcinoma. , 2006, Neoplasia.
[12] J. Conroy,et al. Prostate-Specific Antigen Modulates Genes Involved in Bone Remodeling and Induces Osteoblast Differentiation of Human Osteosarcoma Cell Line SaOS-2 , 2006, Clinical Cancer Research.
[13] G. Mundy. Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities , 2002, Nature Reviews Cancer.
[14] J. H. Lee,et al. Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. , 1997, Cancer research.
[15] C. Bucana,et al. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[16] Rebecca Aucoin,et al. Brain metastases in melanoma: roles of neurotrophins. , 2004, Neuro-oncology.
[17] D. Peehl,et al. CXCR4 and CXCL12 (SDF-1) in Prostate Cancer , 2004, Clinical Cancer Research.
[18] Andy J. Minn,et al. Genes that mediate breast cancer metastasis to lung , 2005, Nature.
[19] P. Steeg. Metastasis suppressors alter the signal transduction of cancer cells , 2003, Nature Reviews Cancer.
[20] S. Mukherji,et al. Cervical nodal metastases in squamous cell carcinoma of the head and neck: What to expect , 2001, Head & neck.
[21] E. Kleinerman,et al. Osterix, a transcription factor for osteoblast differentiation, mediates antitumor activity in murine osteosarcoma. , 2005, Cancer research.
[22] L. Ellis,et al. Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis. , 2000, Cancer research.
[23] J. Li,et al. Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase. , 2000, Cancer research.
[24] S. Steinberg,et al. Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain. , 2007, Cancer research.
[25] Bingham Ja. Letter: Lower oesophageal sphincter. , 1974 .
[26] M. Kasuga,et al. High Expression of PRL-3 Promotes Cancer Cell Motility and Liver Metastasis in Human Colorectal Cancer , 2004, Clinical Cancer Research.
[27] K. Miura,et al. Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression , 2006, Nature Medicine.
[28] O. S. Nielsen,et al. Bone metastases: pathophysiology and management policy. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] J M Trent,et al. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. , 1996, Journal of the National Cancer Institute.
[30] G. Nicolson,et al. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations. , 1996, Cancer research.
[31] J. Myers,et al. Extent of extracapsular spread , 2003, Cancer.
[32] Jian Hui Wu,et al. Differential metastasis-associated gene analysis of prostate carcinoma cells derived from primary tumor and spontaneous lymphatic metastasis in nude mice with orthotopic implantation of PC-3M cells. , 2006, Cancer letters.
[33] G. Roodman. Mechanisms of bone metastasis. , 2004, Discovery medicine.
[34] A. Iwamatsu,et al. Activation of ErbB3–PI3-kinase pathway is correlated with malignant phenotypes of adenocarcinomas , 2003, Oncogene.
[35] M. Mehta,et al. Current management of brain metastases, with a focus on systemic options. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] A. Pappo,et al. Brain metastases in children with melanoma , 1997, Cancer.
[37] I. Fidler,et al. Critical determinants of metastasis. , 2002, Seminars in cancer biology.
[38] Suyun Huang,et al. Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice , 2004, Clinical & Experimental Metastasis.
[39] P. Kostenuik,et al. Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis. , 2001, Cancer research.
[40] W. Dougall,et al. The RANK/RANKL/OPG triad in cancer-induced bone diseases , 2007, Cancer and Metastasis Reviews.
[41] Hans Clevers,et al. Wnt/β-Catenin Signaling in Development and Disease , 2006, Cell.
[42] Philip Lijnzaad,et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas , 2005, Nature Genetics.
[43] F. Bérard,et al. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype. , 2000, Cancer research.
[44] D. L. Kinsey. An experimental study of preferential metastasis , 1960, Cancer.
[45] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[46] A. Dachman,et al. Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] J. Nelson,et al. Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate , 1995, Nature Medicine.
[48] A. Cox,et al. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. , 2006, Cancer research.
[49] K. Kim,et al. KAI1 COOH-Terminal Interacting Tetraspanin (KITENIN), a Member of the Tetraspanin Family, Interacts with KAI1, a Tumor Metastasis Suppressor, and Enhances Metastasis of Cancer , 2004, Cancer Research.
[50] Yusuke Nakamura,et al. Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs , 2003, Oncogene.
[51] W. Dougall,et al. Soluble receptor activator of nuclear factor kappaB Fc diminishes prostate cancer progression in bone. , 2003, Cancer research.
[52] A. Ryan,et al. Inhibition of Src Tyrosine Kinase as Treatment for Human Pancreatic Cancer Growing Orthotopically in Nude Mice , 2004, Clinical Cancer Research.
[53] G. Stein,et al. Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells. , 2003, Cancer research.
[54] M. Seibel,et al. Mechanisms of Disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis , 2006, Nature Clinical Practice Oncology.
[55] Stephen M Hewitt,et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis , 2004, Nature Medicine.
[56] G. Stein,et al. Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone , 2006, Cancer and Metastasis Reviews.
[57] D. Huylebroeck,et al. Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors , 1996, Molecular and Cellular Endocrinology.
[58] J. Deng,et al. The Novel Zinc Finger-Containing Transcription Factor Osterix Is Required for Osteoblast Differentiation and Bone Formation , 2002, Cell.
[59] S. Goodison,et al. The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. , 2005, Cancer research.
[60] I. Fidler,et al. The organ microenvironment and cancer metastasis. , 2002, Differentiation; research in biological diversity.
[61] S. Powers,et al. Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[62] Michiie Sakamoto,et al. Growth and spread of hepatocellular carcinoma: A review of 240 consecutive autopsy cases , 1990, Cancer.
[63] Abraham Schneider,et al. Skeletal Localization and Neutralization of the SDF‐1(CXCL12)/CXCR4 Axis Blocks Prostate Cancer Metastasis and Growth in Osseous Sites In Vivo , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[64] J. Li,et al. PRL-3 and PRL-1 promote cell migration, invasion, and metastasis. , 2003, Cancer research.
[65] O. Kozawa,et al. Endothelin-1 induces vascular endothelial growth factor synthesis in osteoblasts: involvement of p38 mitogen-activated protein kinase. , 2000, Cellular signalling.
[66] J. Price,et al. Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[67] P. Steeg. Perspectives on classic article: metastasis suppressor genes. , 2004, Journal of the National Cancer Institute.
[68] X. Wang,et al. Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning , 2003, Nature Medicine.
[69] L. Ellis,et al. Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[70] R. Scolyer,et al. Cytoplasmic expression of nm23 predicts the potential for cerebral metastasis in patients with primary cutaneous melanoma , 2004, Melanoma research.
[71] E. Sugarbaker. The organ selectivity of experimentally induced metastases in rats , 1952, Cancer.
[72] J. Hecht,et al. Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[73] A. Ochiai,et al. Prostate‐specific antigen induces apoptosis of osteoclast precursors: Potential Role in osteoblastic bone metastases of prostate cancer , 2006, The Prostate.
[74] D. Brigstock,et al. Connective tissue growth factor: what's in a name? , 2000, Molecular genetics and metabolism.
[75] L. Chung,et al. Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment , 1999, The Prostate.
[76] A. Potti,et al. Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications. , 2004, Cancer.
[77] Patrick Kemmeren,et al. Multiple robust signatures for detecting lymph node metastasis in head and neck cancer. , 2006, Cancer research.
[78] C. Cordon-Cardo,et al. A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.
[79] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[80] E. Winer,et al. Brain Metastases: The HER2 Paradigm , 2007, Clinical Cancer Research.
[81] L. Mccauley,et al. Skeletal metastasis: Established and emerging roles of parathyroid hormone related protein (PTHrP) , 2007, Cancer and Metastasis Reviews.
[82] O. Nishimura,et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor , 2001, Nature.
[83] N. Gebbia,et al. Activin A circulating levels in patients with bone metastasis from breast or prostate cancer , 2006, Clinical & Experimental Metastasis.
[84] F. Holstege,et al. Dissection of a metastatic gene expression signature into distinct components , 2006, Genome Biology.
[85] H. Clevers. Wnt/beta-catenin signaling in development and disease. , 2006, Cell.
[86] S Paget,et al. THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .
[87] Y-j Liu,et al. Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro- and antimetastatic activity, respectively , 2006, Oncogene.
[88] K. Pienta,et al. Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[89] A. Tumber,et al. Breast cancer cells induce osteoclast formation by stimulating host IL‐11 production and downregulating granulocyte/macrophage colony‐stimulating factor , 2004, International journal of cancer.
[90] T. L. Drell,et al. Effects of Neurotransmitters on the Chemokinesis and Chemotaxis of MDA-MB-468 Human Breast Carcinoma Cells , 2003, Breast Cancer Research and Treatment.
[91] C. Bucana,et al. Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin. , 1981, Journal of the National Cancer Institute.
[92] D. Kirsch,et al. Survival after brain metastases from breast cancer in the trastuzumab era. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[93] E. Abe. Function of BMPs and BMP Antagonists in Adult Bone , 2006, Annals of the New York Academy of Sciences.
[94] C. Logothetis,et al. Osteoblasts in prostate cancer metastasis to bone , 2005, Nature Reviews Cancer.
[95] M. Kattan,et al. Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[96] M. Noda,et al. Endothelin modulates osteopontin and osteocalcin messenger ribonucleic acid expression in rat osteoblastic osteosarcoma cells , 1993, Journal of cellular biochemistry.
[97] S. Aaronson,et al. Prostate cancer cells promote osteoblastic bone metastases through Wnts. , 2005, Cancer research.
[98] Charles Cha,et al. Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab. , 2006, Clinical colorectal cancer.
[99] I. Fidler,et al. Selection of successive tumour lines for metastasis. , 1973, Nature: New biology.
[100] F. Holstege,et al. Maintenance of head and neck tumor gene expression profiles upon lymph node metastasis. , 2006, Cancer research.
[101] K. Shitara,et al. Blockade of Paracrine Supply of Insulin-Like Growth Factors Using Neutralizing Antibodies Suppresses the Liver Metastasis of Human Colorectal Cancers , 2005, Clinical Cancer Research.
[102] I. Fidler,et al. Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. , 1980, Cancer research.
[103] Michael A. Choti,et al. A Phosphatase Associated with Metastasis of Colorectal Cancer , 2001, Science.
[104] G. Stein,et al. Fidelity of Runx2 Activity in Breast Cancer Cells Is Required for the Generation of Metastases-Associated Osteolytic Disease , 2004, Cancer Research.
[105] Yi Lu,et al. Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism. , 2005, Cancer research.
[106] H. Mehdorn,et al. Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases , 2005, Journal of Cancer Research and Clinical Oncology.
[107] A. Mizokami,et al. Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone. , 2001, The Journal of clinical investigation.
[108] I. Asahina,et al. Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells. , 1996, Experimental cell research.
[109] I. Holen,et al. Osteoprotegerin (OPG) Produced by Bone Marrow Stromal Cells Protects Breast Cancer Cells from TRAIL-Induced Apoptosis , 2004, Breast Cancer Research and Treatment.
[110] Suyun Huang. Regulation of Metastases by Signal Transducer and Activator of Transcription 3 Signaling Pathway: Clinical Implications , 2007, Clinical Cancer Research.
[111] K. Aldape,et al. Activation of stat3 in human melanoma promotes brain metastasis. , 2006, Cancer research.
[112] Sunil Singhal,et al. Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity , 2005, Oncogene.
[113] L. Suva,et al. Heparanase promotes the spontaneous metastasis of myeloma cells to bone. , 2004, Blood.